Wikidata

(Q61920867)

English

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

clinical trial

In more languages

Statements

short name
ADVANCE-2 (English)
0 references
title
A Phase 3, Randomized, Double-blind, Active-controlled (Enoxaparin 40 mg QD), Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery (The ADVANCE - 2 Study) (English)
0 references
medical condition
thrombosis
0 references
embolism
0 references
pulmonary embolism
0 references
country
Austria
0 references
Belgium
0 references
Brazil
0 references
Chile
0 references
Colombia
0 references
Czech Republic
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
India
0 references
Israel
0 references
Italy
0 references
Malaysia
0 references
Mexico
0 references
Norway
0 references
Philippines
0 references
Poland
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Ukraine
0 references
United Kingdom
0 references
start time
June 2007
0 references
end time
January 2009
0 references
number of participants
3,221
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61920867&oldid=2104303785"